Goldman Sachs Upgrades Alexion Pharmaceuticals (ALXN) to Buy
Tweet
Share
E-mail
Get Alerts ALXN Hot Sheet
Price: $182.01 --0%
Rating Summary:
10 Buy, 25 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 9 | Down: 7 | New: 5
Rating Summary:
10 Buy, 25 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 9 | Down: 7 | New: 5
Join SI Premium – FREE
Goldman Sachs upgraded Alexion Pharmaceuticals (NASDAQ: ALXN) from Neutral to Buy with a price target of $158.00.
For an analyst ratings summary and ratings history on Alexion Pharmaceuticals click here. For more ratings news on Alexion Pharmaceuticals click here.
Shares of Alexion Pharmaceuticals closed at $131.37 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Freedom Broker Upgrades Freeport-McMoRan (FCX) to Buy
- Goldman Sachs Upgrades Neste Oyj (NESTE:FH) (NTOIY) to Buy
- New Street Research Upgrades Planet Labs (PL) to Neutral
Create E-mail Alert Related Categories
UpgradesRelated Entities
Goldman SachsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
